Yin T - Search Results

1

Genetic variations of CYP2C9 in 724 Japanese individuals and their impact on the antihypertensive effects of losartan.

Yin T, Maekawa K, Kamide K, Saito Y, Hanada H, Miyashita K, Kokubo Y, Akaiwa Y, Otsubo R, Nagatsuka K, Otsuki T, Horio T, Takiuchi S, Kawano Y, Minematsu K, Naritomi H, Tomoike H, Sawada J, Miyata T. Yin T, et al. Hypertens Res. 2008 Aug;31(8):1549-57. doi: 10.1291/hypres.31.1549. Hypertens Res. 2008. PMID: 18971529

2

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives.

Yin T, Miyata T. Yin T, et al. Thromb Res. 2007;120(1):1-10. doi: 10.1016/j.thromres.2006.10.021. Epub 2006 Dec 11. Thromb Res. 2007. PMID: 17161452 Review.

3

No association between vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) and the variability of warfarin dose requirement in a Japanese patient population.

Yin T, Hanada H, Miyashita K, Kokubo Y, Akaiwa Y, Otsubo R, Nagatsuka K, Otsuki T, Okayama A, Minematsu K, Naritomi H, Tomoike H, Miyata T. Yin T, et al. Thromb Res. 2008;122(2):179-84. doi: 10.1016/j.thromres.2007.09.015. Epub 2007 Nov 9. Thromb Res. 2008. PMID: 17996924 No abstract available.

4

Pharmacogenomics of clopidogrel: evidence and perspectives.

Yin T, Miyata T. Yin T, et al. Thromb Res. 2011 Oct;128(4):307-16. doi: 10.1016/j.thromres.2011.04.010. Epub 2011 May 18. Thromb Res. 2011. PMID: 21592545 Review.

5

Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians.

Yin T, Miyata T. Yin T, et al. J Thromb Thrombolysis. 2014 Jan;37(1):56-65. doi: 10.1007/s11239-013-1005-x. J Thromb Thrombolysis. 2014. PMID: 24233386 Review.

6

Protein S K196E mutation, a genetic risk factor for venous thromboembolism, is limited to Japanese.

Liu W, Yin T, Okuda H, Harada KH, Li Y, Xu B, Yang J, Wang H, Fan X, Koizumi A, Miyata T. Liu W, et al. Among authors: yin t. Thromb Res. 2013 Aug;132(2):314-5. doi: 10.1016/j.thromres.2013.05.008. Epub 2013 May 27. Thromb Res. 2013. PMID: 23721692 No abstract available.

7

A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency.

Yin T, Takeshita S, Sato Y, Sakata T, Shin Y, Honda S, Kawasaki T, Tsuji H, Kojima T, Madoiwa S, Sakata Y, Murata M, Ikeda Y, Miyata T. Yin T, et al. Thromb Haemost. 2007 Oct;98(4):783-9. doi: 10.1160/th07-03-0211. Thromb Haemost. 2007. PMID: 17938802

8

Extremely low warfarin dose in patients with genotypes of CYP2C9*3/*3 and VKORC1-1639A/A.

Gao L, He L, Luo J, Xu B, Yang J, Zhang YX, Yang T, Li K, Tian JW, Wang HJ, Zhao YS, Lu CY, Zhang WZ, Yin T. Gao L, et al. Among authors: yin t. Chin Med J (Engl). 2011 Sep;124(17):2767-70. Chin Med J (Engl). 2011. PMID: 22040439

9

Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: a systematic review and meta-analysis.

Yang J, Chen Y, Li X, Wei X, Chen X, Zhang L, Zhang Y, Xu Q, Wang H, Li Y, Lu C, Chen W, Zeng C, Yin T. Yang J, et al. Among authors: yin t. Int J Cardiol. 2013 Oct 9;168(4):4234-43. doi: 10.1016/j.ijcard.2013.07.151. Epub 2013 Aug 7. Int J Cardiol. 2013. PMID: 23932037 Review.

10

A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.

Chen Y, Yin T, Xi S, Zhang S, Yan H, Tang Y, Qian J, Chen J, Su X, Du Z, Wang L, Qin Q, Gao C, Zheng Y, Zhao X, Cheng X, Li Z, Zhang W, Chen H, Wang J, Yang Z, Li H, Liu H, Zhou X, Qu B, Xiang D, Guo Y, Wang L, Nie S, Fu G, Yang M, Cai S. Chen Y, et al. Among authors: yin t. Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1194-1204. doi: 10.1002/ccd.28325. Epub 2019 May 21. Catheter Cardiovasc Interv. 2019. PMID: 31112635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,490 results

Search Page